Heron Therapeutics (HRTX) EBT Margin (2010 - 2026)
Heron Therapeutics' EBT Margin came in at -5.43% for Q2 2026, down 1.03 percentage points from -4.40% a year earlier but up 8.30 percentage points from the prior quarter.
Powered by 
Analysis
Heron Therapeutics (HRTX) EBT Margin (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Heron Therapeutics reported EBT Margin of -7.19%, down 8.01 percentage points year-over-year; for FY2025, it came in at -6.58%, up 3.13 percentage points from FY2024.
- EBT Margin has increased in each of the last five years, with a five-year change of +248.87 percentage points (FY2020 to FY2025).
- Going back by year, EBT Margin was -9.71% in FY2024 (+77.76 pp), -87.46% in FY2023 (+75.52 pp), -162.99% in FY2022 (+91.57 pp) and -254.56% in FY2021 (+0.89 pp).
- The five-year range for quarterly EBT Margin is -268.25% (Q1 2022) to 10.23% (Q4 2024).
- Year-over-year, EBT Margin has declined for three consecutive quarters, with an average year-over-year change of +13.89 percentage points over the last eight quarters.
- The fastest year-over-year change in EBT Margin over five years came in Q4 2022 (a gain of 191.41 percentage points), and the weakest in Q1 2026 (a drop of 21.83 percentage points).
- Business Quant data shows HRTX's EBT Margin at -13.73% (Q1 2026), 0.09% (Q4 2025) and -10.71% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 41.75% |
| 10 | Heron Therapeutics | 58.85 Mn | -130.71 Mn | 26.09 Mn | -5.43% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -5.43% |
| Mar 31, 2026 | -13.73% |
| Dec 31, 2025 | 0.09% |
| Sep 30, 2025 | -10.71% |
| Jun 30, 2025 | -4.40% |
| Mar 31, 2025 | 8.11% |
| Dec 31, 2024 | 10.23% |
| Sep 30, 2024 | -13.59% |
| Jun 30, 2024 | -17.89% |
| Mar 31, 2024 | -13.84% |
| Dec 31, 2023 | -29.85% |
| Sep 30, 2023 | -79.31% |
| Jun 30, 2023 | -133.50% |
| Mar 31, 2023 | -111.64% |
| Dec 31, 2022 | -67.79% |
| Sep 30, 2022 | -157.71% |
| Jun 30, 2022 | -179.15% |
| Mar 31, 2022 | -268.25% |
| Dec 31, 2021 | -259.20% |
| Sep 30, 2021 | -222.59% |
API Access
Heron Therapeutics EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=HRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "HRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=HRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();